Healthcare ❯ Pharmaceuticals

Obesity Treatment

Wegovy Weight Loss Drugs GLP-1 Medications Weight Management GLP-1 Drugs Novo Nordisk Zepbound GLP-1 Injections CT-388 Weight-loss Drugs Injectable Medications Biotechnology GLP-1 Receptor Agonists Mounjaro Drug Development Diabetes Treatment GLP-1 Hormones Weight Loss Mechanism Medication Discontinuation Weight Loss Medications Clinical Trials Competitors

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Soaring GLP‑1 sales, plus expectations for an oral obesity pill, lifted the drugmaker to the milestone.

Eli Lilly Briefly Hits $1 Trillion, First Drugmaker to Reach the Milestone

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.